TY - JOUR
T1 - Cell cycle-regulated modification of the ribosome by a variant multiubiquitin chain
AU - Spence, Jean
AU - Gali, Rayappa Reddy
AU - Dittmar, Gunnar
AU - Sherman, Fred
AU - Karin, Michael
AU - Finley, Daniel
N1 - Funding Information:
We would particularly like to thank Corinne John for carrying out the drug-sensitivity tests, Chris Larsen for generous help in constructing figures, and Curt Wittenberg and Karin Flick for assistance in cell cycle–related experiments. We also thank Steve Reed, Alan Sachs, and Ron Kopito for yeast strains and plasmids; Howard Fried for the generous gifts of trichodermin, strains, and advice; Art Haas for anti-ubiquitin antibodies; and, for comments on the manuscript, Cecile Pickart, Marion Schmidt, Alan Sachs, and Robin Reed. Supported by NIH grants GM12702 (to F. S.) and GM43601 (to D. F.), and DOE grant FG03-86ER60429 (to M. K). G. D. was supported by a fellowship from the Deutsche Forschungsgemeinschaft.
PY - 2000/7/7
Y1 - 2000/7/7
N2 - Ubiquitin is ligated to L28, a component of the large ribosomal subunit, to form the most abundant ubiquitin-protein conjugate in S. cerevisiae. The human ortholog of L28 is also ubiquitinated, indicating that this modification is highly conserved in evolution. During S phase of the yeast cell cycle, L28 is strongly ubiquitinated, while reduced levels of L28 ubiquitination are observed in G1 cells. L28 ubiquitination is inhibited by a Lys63 to Arg substitution in ubiquitin, indicating that L28 is modified by a variant, Lys63-linked multiubiquitin chain. The K63R mutant of ubiquitin displays defects in ribosomal function in vivo and in vitro, including a dramatic sensitivity to translational inhibitors. L28, like other ribosomal proteins, is metabolically stable. Therefore, these data suggest a regulatory role for multiubiquitin chains that is reversible and does not function to target the acceptor protein for degradation.
AB - Ubiquitin is ligated to L28, a component of the large ribosomal subunit, to form the most abundant ubiquitin-protein conjugate in S. cerevisiae. The human ortholog of L28 is also ubiquitinated, indicating that this modification is highly conserved in evolution. During S phase of the yeast cell cycle, L28 is strongly ubiquitinated, while reduced levels of L28 ubiquitination are observed in G1 cells. L28 ubiquitination is inhibited by a Lys63 to Arg substitution in ubiquitin, indicating that L28 is modified by a variant, Lys63-linked multiubiquitin chain. The K63R mutant of ubiquitin displays defects in ribosomal function in vivo and in vitro, including a dramatic sensitivity to translational inhibitors. L28, like other ribosomal proteins, is metabolically stable. Therefore, these data suggest a regulatory role for multiubiquitin chains that is reversible and does not function to target the acceptor protein for degradation.
UR - http://www.scopus.com/inward/record.url?scp=0034616943&partnerID=8YFLogxK
U2 - 10.1016/S0092-8674(00)00011-8
DO - 10.1016/S0092-8674(00)00011-8
M3 - Article
C2 - 10929714
AN - SCOPUS:0034616943
SN - 0092-8674
VL - 102
SP - 67
EP - 76
JO - Cell
JF - Cell
IS - 1
ER -